OpenVSafe by OpenVAERS
Search V-safe

W5R-22736-13180

3 vaccinations 3 coded responses 8 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
015 / MA
Registered
2021-01-26
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-26
    Dose 1 — Moderna
  2. 2021-01-26
    Registered in v-safe
  3. 2021-01-26
    Dose 2 — Moderna
  4. 2021-01-26
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  7. 2021-02-04
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-02-11
    Survey response — day 14, dose 2
    MedDRA: Pyrexia — Feeling: Good · Be unable to work
    Free text: Fever yesterday of 100.7po
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-10-22
    Dose 3 — Moderna
  10. 2021-10-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness · Headache, Fatigue or tiredness
    Adult check-in
  11. 2022-04-22
    Survey response — 6 months, dose 3
    MedDRA: Idiopathic intracranial hypertension — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Idiopathic intracranial hypertension
    MedDRA releases: 2024-11 · check-in free text available
  12. 2022-04-22
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  13. 2022-04-28
    Call successful
    Participant prefers to complete VAERS report online
  14. 2022-10-22
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-26Moderna
22021-01-26Moderna
32021-10-22Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-04-22 Successful
2022-04-28
Participant prefers to complete VAERS report online

Free text

Release 4 — day 14, dose 2

2021-02-11

Symptoms: Fever yesterday of 100.7po

Release 11 — 6 months, dose 3

2022-04-22

Symptoms: Idiopathic intracranial hypertension

Release 12 — 12 months, dose 3

2022-10-22

Symptoms: Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDIdiopathic intracranial hypertension · · ✓
SDPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release